Exact Mass: 507.30182800000006
Exact Mass Matches: 507.30182800000006
Found 500 metabolites which its exact mass value is equals to given mass value 507.30182800000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Eldelin
C27H41NO8 (507.28320260000004)
Deltaline is a diterpene alkaloid, a tertiary alcohol, a tertiary amino compound, an acetate ester, a cyclic acetal and an organic polycyclic compound. It derives from a hydride of an aconitane. Deltaline is a natural product found in Delphinium cheilanthum, Delphinium andersonii, and other organisms with data available. Deltaline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6836-11-9 (retrieved 2024-07-09) (CAS RN: 6836-11-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1]. Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1].
LysoPE(0:0/20:1(11Z))
C25H50NO7P (507.33247200000005)
LysoPE(0:0/20:1(11Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:1(11Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(20:1(11Z)/0:0)
C25H50NO7P (507.33247200000005)
LysoPE(20:1(11Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:1(11Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Chenodeoxycholylaspartic acid
Chenodeoxycholylaspartic acid belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylaspartic acid consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Aspartic acid conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylaspartic acid, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylaspartic acid appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
(1S,10S,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Deltaline
C27H41NO8 (507.28320260000004)
Lefamulin
C28H45NO5S (507.30182800000006)
Broussonetine A
C24H45NO10 (507.30433100000005)
Broussonetine A is a natural product found in Broussonetia kazinoki with data available.
(2E,6E,12E)-18-(2,6-Dioxo-4-piperidinyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxo-2,6,12-octadecatrienoic acid
C27H41NO8 (507.28320260000004)
Phosphatidylethanolamine lyso 20:1
C25H50NO7P (507.33247200000005)
(2E,6E,11E)-18-(2,6-dioxopiperidin-4-yl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,11-trienoic acid
C27H41NO8 (507.28320260000004)
ACE inhibitor peptide C 107|Ala-Leu-Pro-His-Ala|ALPHA
Val Phe Lys Asp
Phe Val Asp Lys
Phe Val Ser Arg
Bonvalotidine A
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
Deltaline
C27H41NO8 (507.28320260000004)
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Delphinium alkaloid Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1]. Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1].
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_major
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_minor
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_30.3\\%
C27H41NO8 (507.28320260000004)
Ala Arg Val Tyr
Ala Arg Tyr Val
Ala Val Arg Tyr
Ala Val Tyr Arg
Ala Tyr Arg Val
Ala Tyr Val Arg
Asp Phe Lys Val
Asp Phe Val Lys
Asp Lys Phe Val
Asp Lys Val Phe
Asp Val Phe Lys
Asp Val Lys Phe
Phe Asp Lys Val
Phe Asp Val Lys
Phe Ile Lys Thr
C25H41N5O6 (507.30566860000005)
Phe Ile Gln Thr
Phe Ile Thr Lys
C25H41N5O6 (507.30566860000005)
Phe Ile Thr Gln
Phe Lys Asp Val
Phe Lys Ile Thr
C25H41N5O6 (507.30566860000005)
Phe Lys Leu Thr
C25H41N5O6 (507.30566860000005)
Phe Lys Thr Ile
C25H41N5O6 (507.30566860000005)
Phe Lys Thr Leu
C25H41N5O6 (507.30566860000005)
Phe Lys Val Asp
Phe Leu Lys Thr
C25H41N5O6 (507.30566860000005)
Phe Leu Gln Thr
Phe Leu Thr Lys
C25H41N5O6 (507.30566860000005)
Phe Leu Thr Gln
Phe Gln Ile Thr
Phe Gln Leu Thr
Phe Gln Thr Ile
Phe Gln Thr Leu
Phe Arg Ser Val
Phe Arg Val Ser
Phe Ser Arg Val
Phe Ser Val Arg
Phe Thr Ile Lys
C25H41N5O6 (507.30566860000005)
Phe Thr Ile Gln
Phe Thr Lys Ile
C25H41N5O6 (507.30566860000005)
Phe Thr Lys Leu
C25H41N5O6 (507.30566860000005)
Phe Thr Leu Lys
C25H41N5O6 (507.30566860000005)
Phe Thr Leu Gln
Phe Thr Gln Ile
Phe Thr Gln Leu
Phe Val Lys Asp
Phe Val Arg Ser
Gly Ile Arg Tyr
Gly Ile Tyr Arg
Gly Leu Arg Tyr
Gly Leu Tyr Arg
Gly Arg Ile Tyr
Gly Arg Leu Tyr
Gly Arg Tyr Ile
Gly Arg Tyr Leu
Gly Tyr Ile Arg
Gly Tyr Leu Arg
Gly Tyr Arg Ile
Gly Tyr Arg Leu
His Pro Arg Val
His Pro Val Arg
His Arg Pro Val
His Arg Val Pro
His Val Pro Arg
His Val Arg Pro
Ile Phe Lys Thr
C25H41N5O6 (507.30566860000005)
Ile Phe Gln Thr
Ile Phe Thr Lys
C25H41N5O6 (507.30566860000005)
Ile Phe Thr Gln
Ile Gly Arg Tyr
Ile Gly Tyr Arg
Ile Lys Phe Thr
C25H41N5O6 (507.30566860000005)
Ile Lys Thr Phe
C25H41N5O6 (507.30566860000005)
Ile Asn Val Tyr
Ile Asn Tyr Val
Ile Gln Phe Thr
Ile Gln Thr Phe
Ile Arg Gly Tyr
Ile Arg Tyr Gly
Ile Thr Phe Lys
C25H41N5O6 (507.30566860000005)
Ile Thr Phe Gln
Ile Thr Lys Phe
C25H41N5O6 (507.30566860000005)
Ile Thr Gln Phe
Ile Val Asn Tyr
Ile Val Tyr Asn
Ile Tyr Gly Arg
Ile Tyr Asn Val
Ile Tyr Arg Gly
Ile Tyr Val Asn
Lys Asp Phe Val
Lys Asp Val Phe
Lys Phe Asp Val
Lys Phe Ile Thr
C25H41N5O6 (507.30566860000005)
Lys Phe Leu Thr
C25H41N5O6 (507.30566860000005)
Lys Phe Thr Ile
C25H41N5O6 (507.30566860000005)
Lys Phe Thr Leu
C25H41N5O6 (507.30566860000005)
Lys Phe Val Asp
Lys Ile Phe Thr
C25H41N5O6 (507.30566860000005)
Lys Ile Thr Phe
C25H41N5O6 (507.30566860000005)
Lys Leu Phe Thr
C25H41N5O6 (507.30566860000005)
Lys Leu Thr Phe
C25H41N5O6 (507.30566860000005)
Lys Pro Thr Tyr
Lys Pro Tyr Thr
Lys Thr Phe Ile
C25H41N5O6 (507.30566860000005)
Lys Thr Phe Leu
C25H41N5O6 (507.30566860000005)
Lys Thr Ile Phe
C25H41N5O6 (507.30566860000005)
Lys Thr Leu Phe
C25H41N5O6 (507.30566860000005)
Lys Thr Pro Tyr
Lys Thr Tyr Pro
Lys Val Asp Phe
Lys Val Phe Asp
Lys Val Val Tyr
C25H41N5O6 (507.30566860000005)
Lys Val Tyr Val
C25H41N5O6 (507.30566860000005)
Lys Tyr Pro Thr
Lys Tyr Thr Pro
Lys Tyr Val Val
C25H41N5O6 (507.30566860000005)
Leu Phe Lys Thr
C25H41N5O6 (507.30566860000005)
Leu Phe Gln Thr
Leu Phe Thr Lys
C25H41N5O6 (507.30566860000005)
Leu Phe Thr Gln
Leu Gly Arg Tyr
Leu Gly Tyr Arg
Leu Lys Phe Thr
C25H41N5O6 (507.30566860000005)
Leu Lys Thr Phe
C25H41N5O6 (507.30566860000005)
Leu Asn Val Tyr
Leu Asn Tyr Val
Leu Gln Phe Thr
Leu Gln Thr Phe
Leu Arg Gly Tyr
Leu Arg Tyr Gly
Leu Thr Phe Lys
C25H41N5O6 (507.30566860000005)
Leu Thr Phe Gln
Leu Thr Lys Phe
C25H41N5O6 (507.30566860000005)
Leu Thr Gln Phe
Leu Val Asn Tyr
Leu Val Tyr Asn
Leu Tyr Gly Arg
Leu Tyr Asn Val
Leu Tyr Arg Gly
Leu Tyr Val Asn
Asn Ile Val Tyr
Asn Ile Tyr Val
Asn Leu Val Tyr
Asn Leu Tyr Val
Asn Val Ile Tyr
Asn Val Leu Tyr
Asn Val Tyr Ile
Asn Val Tyr Leu
Asn Tyr Ile Val
Asn Tyr Leu Val
Asn Tyr Val Ile
Asn Tyr Val Leu
Pro His Arg Val
Pro His Val Arg
Pro Lys Thr Tyr
Pro Lys Tyr Thr
Pro Arg His Val
Pro Arg Val His
Pro Thr Lys Tyr
Pro Thr Tyr Lys
Pro Val His Arg
Pro Val Arg His
Pro Tyr Lys Thr
Pro Tyr Thr Lys
Gln Phe Ile Thr
Gln Phe Leu Thr
Gln Phe Thr Ile
Gln Phe Thr Leu
Gln Ile Phe Thr
Gln Ile Thr Phe
Gln Leu Phe Thr
Gln Leu Thr Phe
Gln Thr Phe Ile
Gln Thr Phe Leu
Gln Thr Ile Phe
Gln Thr Leu Phe
Gln Val Val Tyr
Gln Val Tyr Val
Gln Tyr Val Val
Arg Ala Val Tyr
Arg Ala Tyr Val
Arg Phe Ser Val
Arg Phe Val Ser
Arg Gly Ile Tyr
Arg Gly Leu Tyr
Arg Gly Tyr Ile
Arg Gly Tyr Leu
Arg His Pro Val
Arg His Val Pro
Arg Ile Gly Tyr
Arg Ile Tyr Gly
Arg Leu Gly Tyr
Arg Leu Tyr Gly
Arg Pro His Val
Arg Pro Val His
Arg Ser Phe Val
Arg Ser Val Phe
Arg Val Ala Tyr
Arg Val Phe Ser
Arg Val His Pro
Arg Val Pro His
Arg Val Ser Phe
Arg Val Tyr Ala
Arg Tyr Ala Val
Arg Tyr Gly Ile
Arg Tyr Gly Leu
Arg Tyr Ile Gly
Arg Tyr Leu Gly
Arg Tyr Val Ala
Ser Phe Arg Val
Ser Phe Val Arg
Ser Arg Phe Val
Ser Arg Val Phe
Ser Val Phe Arg
Ser Val Arg Phe
Thr Phe Ile Lys
C25H41N5O6 (507.30566860000005)
Thr Phe Ile Gln
Thr Phe Lys Ile
C25H41N5O6 (507.30566860000005)
Thr Phe Lys Leu
C25H41N5O6 (507.30566860000005)
Thr Phe Leu Lys
C25H41N5O6 (507.30566860000005)
Thr Phe Leu Gln
Thr Phe Gln Ile
Thr Phe Gln Leu
Thr Ile Phe Lys
C25H41N5O6 (507.30566860000005)
Thr Ile Phe Gln
Thr Ile Lys Phe
C25H41N5O6 (507.30566860000005)
Thr Ile Gln Phe
Thr Lys Phe Ile
C25H41N5O6 (507.30566860000005)
Thr Lys Phe Leu
C25H41N5O6 (507.30566860000005)
Thr Lys Ile Phe
C25H41N5O6 (507.30566860000005)
Thr Lys Leu Phe
C25H41N5O6 (507.30566860000005)
Thr Lys Pro Tyr
Thr Lys Tyr Pro
Thr Leu Phe Lys
C25H41N5O6 (507.30566860000005)
Thr Leu Phe Gln
Thr Leu Lys Phe
C25H41N5O6 (507.30566860000005)
Thr Leu Gln Phe
Thr Pro Lys Tyr
Thr Pro Tyr Lys
Thr Gln Phe Ile
Thr Gln Phe Leu
Thr Gln Ile Phe
Thr Gln Leu Phe
Thr Tyr Lys Pro
Thr Tyr Pro Lys
Val Ala Arg Tyr
Val Ala Tyr Arg
Val Asp Phe Lys
Val Asp Lys Phe
Val Phe Asp Lys
Val Phe Arg Ser
Val Phe Ser Arg
Val His Pro Arg
Val His Arg Pro
Val Ile Asn Tyr
Val Ile Tyr Asn
Val Lys Asp Phe
Val Lys Phe Asp
Val Lys Val Tyr
C25H41N5O6 (507.30566860000005)
Val Lys Tyr Val
C25H41N5O6 (507.30566860000005)
Val Leu Asn Tyr
Val Leu Tyr Asn
Val Asn Ile Tyr
Val Asn Leu Tyr
Val Asn Tyr Ile
Val Asn Tyr Leu
Val Pro His Arg
Val Pro Arg His
Val Gln Val Tyr
Val Gln Tyr Val
Val Arg Ala Tyr
Val Arg Phe Ser
Val Arg His Pro
Val Arg Pro His
Val Arg Ser Phe
Val Arg Tyr Ala
Val Ser Phe Arg
Val Ser Arg Phe
Val Val Lys Tyr
C25H41N5O6 (507.30566860000005)
Val Val Gln Tyr
Val Val Tyr Lys
C25H41N5O6 (507.30566860000005)
Val Val Tyr Gln
Val Tyr Ala Arg
Val Tyr Ile Asn
Val Tyr Lys Val
C25H41N5O6 (507.30566860000005)
Val Tyr Leu Asn
Val Tyr Asn Ile
Val Tyr Asn Leu
Val Tyr Gln Val
Val Tyr Arg Ala
Val Tyr Val Lys
C25H41N5O6 (507.30566860000005)
Val Tyr Val Gln
Tyr Ala Arg Val
Tyr Ala Val Arg
Tyr Gly Ile Arg
Tyr Gly Leu Arg
Tyr Gly Arg Ile
Tyr Gly Arg Leu
Tyr Ile Gly Arg
Tyr Ile Asn Val
Tyr Ile Arg Gly
Tyr Lys Val Val
C25H41N5O6 (507.30566860000005)
Tyr Leu Gly Arg
Tyr Leu Arg Gly
Tyr Arg Ala Val
Tyr Arg Gly Ile
Tyr Arg Gly Leu
Tyr Arg Ile Gly
Tyr Arg Leu Gly
Tyr Arg Val Ala
Tyr Val Ala Arg
Tyr Val Lys Val
C25H41N5O6 (507.30566860000005)
Tyr Val Arg Ala
Tyr Val Val Lys
C25H41N5O6 (507.30566860000005)
LysoPE(20:1/0:0)
C25H50NO7P (507.33247200000005)
NA 27:7;O7
C27H41NO8 (507.28320260000004)
GSK1070916
C30H33N7O (507.27464480000003)
Latanoprostene Bunod
C27H41NO8 (507.28320260000004)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
Lefamulin
C28H45NO5S (507.30182800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
Elacytarabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Elacytarabine (CP 4055) is a lipid-conjugated derivative of the nucleoside analog cytarabine. Elacytarabine (CP 4055) is an antineoplastic agent with cytotoxicity in solid tumors.
BC-3781 intravenous
C28H45NO5S (507.30182800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Xenleta
C28H45NO5S (507.30182800000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
[5-[[6-[5-(4,7-Dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl)-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate
C27H41NO8 (507.28320260000004)
(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
3-cyclohexyl-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
2-[(1R,3R,4aS,9aR)-6-(cyclohexylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
2-[(1R,3S,4aR,9aS)-6-(cyclohexylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3S,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
4-[[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
2-[(1S,3S,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1R,3S,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
4-[[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
ethyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
2-[(1R,3R,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3R,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3R,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
(3E)-3-[[4-(Dimethylamino)phenyl]methylidene]-2-morpholin-4-yl-N-(3,4,5-trimethoxyphenyl)cyclohexene-1-carboxamide
C29H37N3O5 (507.27330720000003)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-icos-11-enoate
C25H50NO7P (507.33247200000005)
[3-[(Z)-heptadec-9-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
[2-butanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] heptanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] pentanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] propanoate
C25H50NO7P (507.33247200000005)
[2-acetyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dec-4-ene-1-sulfonic acid
C28H45NO5S (507.30182800000006)
(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid
C28H45NO5S (507.30182800000006)
[2-propanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
4-[3-acetyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] butanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] hexanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] acetate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate
[3-propanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[3-acetyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
LysoPC(17:1/0:0)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-icos-11-enoate
C25H50NO7P (507.33247200000005)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-icos-13-enoate
C25H50NO7P (507.33247200000005)
1-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine
C25H50NO7P (507.33247200000005)
FR901464
C27H41NO8 (507.28320260000004)
A spiro-epoxide with potent anticancer activity that lowers the mRNA levels of oncogenes and tumour supressor genes. It is isolated from Pseudomonas sp. no.2663.
1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine
C25H50NO7P (507.33247200000005)
A 1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (10Z)-heptadecenoyl.
1-(9Z-heptadecenoyl)-glycero-3-phosphocholine
C25H50NO7P (507.33247200000005)
lysophosphatidylcholine 17:1
C25H50NO7P (507.33247200000005)
A lysophosphatidylcholine in which the remaining acyl group contains 17 carbons and 1 double bond. If R1 is acyl and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is acyl then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylethanolamine 20:1
C25H50NO7P (507.33247200000005)
A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 1 double bond.
PC(16:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(15:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(19:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(18:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(16:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePE(18:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
NA-DOPA 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C31H41NO5 (507.29845760000006)
(2e,6e,12e)-9,11-dihydroxy-18-(2-hydroxy-6-oxo-4,5-dihydro-3h-pyridin-4-yl)-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
1-hydroxy-13-[4-hydroxy-5-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyrrolidin-2-yl]tridecan-4-one
C24H45NO10 (507.30433100000005)
(2e,6e,8s,9s,10r,11r,12e,14s)-9,11-dihydroxy-18-(2-hydroxy-6-oxo-4,5-dihydro-3h-pyridin-4-yl)-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
n-[(2s,3r,4r,5s,6r)-2-{[(1s,2s,4ar,4bs,7s,10ar)-7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
(1r,2s,3s,4s,5r,6s,8r,12r,13s,16r,19s,20r,21s)-14-ethyl-2-hydroxy-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-yl acetate
C27H41NO8 (507.28320260000004)
4-(acetyloxy)-11-ethyl-6,16-dihydroxy-18-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate
C27H41NO8 (507.28320260000004)
(2e,4s)-4-(acetyloxy)-n-[(2r,5s,6s)-6-[(2e,4e)-5-[(4r,5r,7s)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dien-1-yl]-2,5-dimethyloxan-3-yl]pent-2-enimidic acid
C27H41NO8 (507.28320260000004)